US Stocks

Caribou Biosciences, Inc.

Caribou Biosciences is a biopharmaceutical company that develops genome-edited allogeneic cell therapies for treating hematologic malignancies and solid tumors in the US and internationally. They have several products in development, including an allogeneic anti-CD19 CAR-T cell therapy and an allogeneic anti-BCMA CAR-T cell therapy. They have a collaboration with AbbVie Manufacturing Management Unlimited Company to develop CAR-T cell therapies.